BioLife Solutions announces special shareholder meeting on merger agreement
BLFS•Special shareholder meeting set for Oct. 5, 2026
BioLife Solutions will hold a special shareholder meeting via remote communication on Oct. 5, 2026.
Shareholders will vote on adopting the merger agreement under which Repligen would acquire BioLife.
Deal terms call for $11.25 in cash plus 0.1442 shares of Repligen common stock per BioLife share.
